ID   82.3
AC   CVCL_A7NJ
DR   Wikidata; Q107113307
RX   PubMed=33922695;
CC   Population: Caucasian; Italian.
CC   Characteristics: Shows cross-resistance to gemcitabine, 5-fluorouracil, carboplatin and oxaliplatin (PubMed=33922695).
CC   Characteristics: Established from a 4th generation xenograft maintained in NOD/SCID mice (PubMed=33922695).
CC   Doubling time: 48-53 hours (PubMed=33922695).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): PubMed=33922695
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 13,16
ST   D21S11: 30
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 10,16
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=33922695; DOI=10.3390/cancers13092051; PMCID=PMC8123022;
RA   Peraldo-Neia, Caterina
RA   Massa, Annamaria
RA   Vita, Francesca
RA   Basirico, Marco
RA   Raggi, Chiara
RA   Bernabei, Paola
RA   Ostano, Paola
RA   Casorzo, Laura
RA   Panero, Mara
RA   Leone, Francesco
RA   Cavalloni, Giuliana
RA   Aglietta, Massimo
RT   "A novel multidrug-resistant cell line from an Italian intrahepatic
RT   cholangiocarcinoma patient.";
RL   Cancers (Basel) 13:2051.1-2051.21(2021).
//